Filtered By:
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 1725 results found since Jan 2013.
Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients
Haematologica. 2023 Jun 22. doi: 10.3324/haematol.2023.283015. Online ahead of print.ABSTRACTAZD7442 (tixagevimab-cilgavimab) is a combination of two human monoclonal antibodies for preexposure prophylaxis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among highrisk patients who do not mount a reliable vaccine response. Foremost among these are hematologic malignancy patients with limited clinical trial or real-world experience to assess the effectiveness of this combination treatment since the emergence of Omicron and its subvariants. We performed a retrospective study of 892 highrisk hematolog...
Source: Haematologica - June 22, 2023 Category: Hematology Authors: Justin C Laracy Judy Yan Samantha N Steiger Carrie A Tan Nina Cohen Elizabeth V Robilotti Jerome Fender Sara Cohen Neha Korde Melissa Lee-Teh Ariela Noy Joseph H Oved Lindsey E Roeker Gunjan Shah N Esther Babady Mini Kamboj Susan K Seo Source Type: research
FDA approves next round of COVID-19 vaccines targeting omicron variant
The next round of COVID-19 vaccines will target one of the latest versions of the coronavirus, the Food and Drug Administration said Friday. FDA's decision came one day after an agency panel of outside advisers supported the recipe change. The agency told vaccine makers to provide protection…#fda #xbb #pfizer
Source: Reuters: Health - June 18, 2023 Category: Consumer Health News Source Type: news
FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant
An F.D.A. advisory panel told manufacturers to aim the latest coronavirus vaccine for the fall at the dominant SARS-CoV-2 variant.
Source: NYT Health - June 15, 2023 Category: Consumer Health News Authors: Christina Jewett Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Coronavirus Omicron Variant Deaths (Fatalities) Centers for Disease Control and Prevention Food and Drug Administration Moderna Inc Pfizer Inc Novavax Inc United States XBB your-fe Source Type: news
Production of singlet oxygen from photosensitizer erythrosine for facile inactivation of coronavirus on mask
This study proposes a PPE disinfection method that uses erythrosine, a U.S. Food and Drug Administration-approved food dye, as photosensitizer to produce singlet oxygen for virus inactivation, and indicates the completion of disinfection by its photobleaching color change.After spraying 100 μL of 10 μM erythrosine on the surface of the mask for 3 times and light exposure for 25 min, the titer of coronavirus decreased by more than 99.999%, and the color of erythrosine on the mask surface disappeared. In addition, the structure of the mask was intact and the filtration efficiency was maintained at > 95% after 10 cycles ...
Source: Environment International - June 2, 2023 Category: Environmental Health Authors: Yunhan Jiang Yulong Fu Xiaojie Xu Xiaoguang Guo Feiyu Wang Xin Xu Yao-Wei Huang Jiyan Shi Chaofeng Shen Source Type: research
EPH43 Potential Association of Remdesivir and Hyperkalemia: A Disproportionality Analysis in USFDA Adverse Event Reporting System Database
Signal detection is one of the most advanced and promising techniques in the world of pharmacovigilance. Remdesivir is approved for emergency use by the US Food and Drug Administration (FDA) for patients with coronavirus disease 2019 (COVID-19). Its benefit- risk ratio is still being explored because data in the field are rather scant. On the other hand hyperkalemia is a potentially life-threatening electrolyte disorder. Severe hyperkalemia can occur suddenly and can cause life-threatening heart rhythm changes (arrhythmia) that cause a heart attack.
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: A. Das, M. Vajapu Source Type: research
When Adolescents Disagree with Their Vaccine-Hesitant Parents about COVID-19 Vaccination
This article discusses parental vaccine hesitancy and argues that permitting independent adolescent consent to COVID-19 vaccination should be an ethical and policy priority as we continue to confront the threat of Omicron and other variants of the coronavirus. We discuss the central role of the pediatric healthcare team in caring for adolescent patients who disagree with their parents about vaccination.PMID:37229735 | DOI:10.1086/724746
Source: Journal of Clinical Ethics - May 25, 2023 Category: Medical Ethics Authors: Robert S Olick Y Tony Yang Jana Shaw Source Type: research
